Literature DB >> 30667488

Aspirin for Primary Prevention: Clinical Considerations in 2019.

J Michael Gaziano1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30667488     DOI： 10.1001/jama.2018.20577

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

1.  Aspirin Use and Misuse for the Primary Prevention of Cardiovascular Diseases.

Authors:  Russell V Luepker; Niki C Oldenburg; Jeffrey R Misialek; Jeremy R Van't Hof; John R Finnegan; Milton Eder; Sue Duval
Journal:  Am J Prev Med       Date:  2021-02-03       Impact factor: 5.043

2.  2019 Chinese expert consensus statement on aspirin application in primary prevention of cardiovascular disease.

Authors:  Xiao-Ying Li; Zhong-Wei Shi; Dong Zhao; Da-Wei Yin
Journal:  Chin Med J (Engl)       Date:  2020-05-20       Impact factor: 2.628

3.  Continuous Inflammatory Stimulation Leads via Metabolic Plasticity to a Prometastatic Phenotype in Triple-Negative Breast Cancer Cells.

Authors:  Dina Morein; Linor Rubinstein-Achiasaf; Hadar Brayer; Orly Dorot; Edward Pichinuk; Hagar Ben-Yaakov; Tsipi Meshel; Metsada Pasmanik-Chor; Adit Ben-Baruch
Journal:  Cells       Date:  2021-05-31       Impact factor: 6.600

Review 4.  Aspirin for primary prevention of cardiovascular disease: Advice for a decisional strategy based on risk stratification.

Authors:  Alberto Aimo; Raffaele De Caterina
Journal:  Anatol J Cardiol       Date:  2020-01       Impact factor: 1.596
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.